We constructed SSL containing immunodominant HLA-A2.1 restricted CTL epitopes derived from Melan-A/MART-1 melanoma TAA (Kawakami et al, 1994; Valmori et al, 1998), and we have analysed their immunogenicity in vitro in comparison with their soluble counterpart. This evidence concerns the gene MLANA and melanoma.